EMERGENT DYNAMICS
DEAD

Serial Number

88732417

Owner

Emergent Dynamics, Inc.

Attorney

Carol H. Peters

Filing Date

Dec 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

EMERGENT DYNAMICS Trademark

Serial Number: 88732417

EMERGENT DYNAMICS is a trademark filed by Emergent Dynamics, Inc. on December 18, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Emergent Dynamics, Inc. (2 trademarks)

6 Justin Court
Saddle River, NJ 07458

Entity Type: 03

Trademark Details

Filing Date

December 18, 2019

Registration Date

Not Registered

Goods & Services

Scientific research, development, and testing services featuring cloud-based, scientific cognitive computing and simulation platforms using artificial intelligence and data for testing scientific empirical queries, generating and testing hypotheses and formulating responses, screening, modeling, and simulating biological and molecular processes and pathways, simulating and automating experimentation and testing, and generating data and contextual analyses and predictive models, all of the aforementioned in the fields of new drug screening and discovery, new drug development, drug improvement, and clinical testing of drugs; Cloud computer services featuring cloud-based, scientific cognitive computing and simulation platforms using artificial intelligence and data for testing scientific empirical queries, generating and testing hypotheses and formulating responses, screening, modeling, and simulating biological and molecular processes and pathways, simulating and automating experimentation and testing, and generating data and contextual analyses and predictive models, all of the aforementioned in the fields of new drug screening and discovery, new drug development, drug improvement, and clinical testing of drugs; and Platform as a service (PAAS) featuring cloud-based, scientific cognitive computing and simulation platforms using artificial intelligence and data for testing scientific empirical queries, generating and testing hypotheses and formulating responses, screening, modeling, and simulating biological and molecular processes and pathways, simulating and automating experimentation and testing, and generating data and contextual analyses and predictive models, all of the aforementioned in the fields of new drug screening and discovery, new drug development, drug improvement, and clinical testing of drugs

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 7, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 7, 2020 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 26, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 26, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 26, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2019 NWOS
NEW APPLICATION ENTERED
Dec 21, 2019 NWAP